Compare Rush Street Interactive Inc (RSI) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs Twist Bioscience Corp — how do they compare? Rush Street Interactive Inc trades at $24.58 (market cap $2.91B), while Twist Bioscience Corp trades at $124.33 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 2.7× Rush Street Interactive Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals.
| RSI | TWST | |
|---|---|---|
Market Cap | $2.91B | $7.72B |
Sector | Technology | Health |
52-Week High | $34.52 | $124.88 |
52-Week Low | $15.89 | $24.16 |
Enterprise Value | $2.57B | $7.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rush Street Interactive (RSI) trades at $25.08, up 1.46% today, with a bearish technical signal but strong analyst support. The company reported record Q2 2026 revenue of $393.8 million, up 46% year-over-year, and raised full-year guidance. Despite a high P/E ratio of 81.13, profitability metrics like a 20.72% ROE and recent earnings beats signal operational strength. Key resistance sits at $26, with support near $24.
The outlook is positive driven by revenue growth and market expansion, but high valuation and mixed technicals pose risks. Analyst consensus is bullish with a $34.75 price target, though regulatory pressures in the gaming sector remain a concern. The stock offers growth potential but requires monitoring of execution and market sentiment.
Twist Bioscience (TWST) trades at $123.76, down 0.9% on the day, with a bullish technical signal from moving averages but bearish oscillators. Revenue growth is strong, with 2025 revenue at $376.57 million, though the company remains unprofitable with a net income margin of -31.66%. Recent news highlights an upsized $300 million public offering and an analyst upgrade, contributing to positive sentiment.
The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, negative cash flow, and high valuation ratios pose significant risks. Investors should weigh the growth trajectory against the path to profitability and cash burn concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
